Citius Oncology announces a $18M fundraise to support the launch of LYMPHIR, a cancer immunotherapy. The offering is backed by a healthcare-focused investor.
Amount Raised
$18 Million
Round Type
Funding Round
CranfordBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Citius Oncology, Inc. has entered into a definitive agreement for a registered direct offering of 1,284,404 shares at $1.09 per share. Additionally, the company will issue warrants for the purchase of shares as part of a concurrent private placement. The funds raised will strengthen its cash position and support the commercial launch of LYMPHIR
Quick answer
Citius Oncology raised $18 Million in a Funding Round round, dated December 9, 2025. Investors: Single Healthcare Focused Investor. Citius Oncology is based in Cranford, New Jersey, United States.
- How much did Citius Oncology raise?
- Citius Oncology raised $18 Million in a Funding Round round on December 9, 2025.
- Who invested in Citius Oncology?
- Single Healthcare Focused Investor is named as investors in this round.
- What does Citius Oncology do?
- Citius Oncology, Inc. is a Delaware-based clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer.
- Where is Citius Oncology based and how big is it?
- Citius Oncology is based in Cranford, New Jersey, United States. Fundz records about 19 employees.
- Who are the decision-makers at Citius Oncology?
- Fundz holds 2 contacts at Citius Oncology, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Citius Oncology that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.5M on January 14, 2026.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- BeyondSpring raised $2M (Funding Round) on November 21, 2025.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
- Navega Therapeutics raised $1.3M (Seed) on January 2, 2026.
Who to call at Citius Oncology, and when
A new round usually means Citius Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Citius Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Citius Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Citius Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Citius Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Citius Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.